Welcome to our dedicated page for Hippo Hldgs SEC filings (Ticker: HIPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hippo Holdings Inc. filings document formal disclosures for a NYSE-listed insurance technology company with common stock trading under HIPO. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentations, supplemental financial information, and reconciliations of non-GAAP measures to GAAP measures.
The company’s proxy filings cover annual meeting materials, stockholder voting matters, board governance, and public-company disclosure requirements. Together, the filing record emphasizes Hippo’s insurance-platform performance, premium and underwriting metrics, capital and equity disclosures, and governance framework.
Richard McCathron, Chief Executive Officer and Director of Hippo Holdings Inc. (HIPO), reported an open-market sale of 10,759 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the reported disposition, McCathron beneficially owned 475,388 shares, which the filing notes includes 212,464 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses the transaction and the remaining stake but does not provide context such as whether the sale was pursuant to a pre-arranged trading plan or for personal reasons.